Literature DB >> 23176145

MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression.

Chen Xin1, Bao Buhe, Lu Hongting, Yang Chuanmin, Hao Xiwei, Zhang Hong, Han Lulu, Dong Qian, Wang Renjie.   

Abstract

In this study, we found that the expression of miR-15a was positively correlated with neuroblastoma (NB) clinical pathological stage and was negatively correlated with reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression. Using the enhanced green fluorescent protein (EGFP) reporter construct carrying the 3'-UTR of RECK, we identified RECK as a direct target of miR-15a. Suppression of miR-15a significantly decreased the migration ability of GI-LA-N and SK-N-SH cell lines, whereas overexpression of miR-15a increased the migration ability; these effects could be partly reversed by RECK inhibition or ectopic expression. Moreover, inhibition of miR-15a significantly increased secreted matrix metalloproteinase-9 expression in culture medium through regulating the expression of RECK. These findings provide new insights into the characteristics of the miR-15a-RECK-matrix metalloproteinase-9 axis in NB progression, especially in NB migration and invasion.
© 2012 The Authors Journal compilation © 2012 FEBS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23176145     DOI: 10.1111/febs.12074

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  22 in total

1.  miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.

Authors:  Christos K Kontos; Panagiotis Tsiakanikas; Margaritis Avgeris; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.

Authors:  Ningning Liu; Tong Jiao; Yan Huang; Wenjun Liu; Zhiwei Li; Xin Ye
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

3.  MiR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells.

Authors:  Haizhou Guo; Qianping Li; Weihao Li; Tianliang Zheng; Song Zhao; Zhangsuo Liu
Journal:  Mol Cell Biochem       Date:  2014-01-29       Impact factor: 3.396

Review 4.  The roles of microRNAs in neuroblastoma.

Authors:  Hong Mei; Zhen-Yu Lin; Qiang-Song Tong
Journal:  World J Pediatr       Date:  2014-01-25       Impact factor: 2.764

5.  Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma.

Authors:  Yu Li; Wei Li; Jian-Guo Zhang; Hai-Yang Li; Yong-Ming Li
Journal:  Tumour Biol       Date:  2014-07-11

Review 6.  MicroRNAs in neuroblastoma: small-sized players with a large impact.

Authors:  Feng Zhi; Rong Wang; Qiang Wang; Lian Xue; Danni Deng; Suinuan Wang; Yilin Yang
Journal:  Neurochem Res       Date:  2014-01-30       Impact factor: 3.996

7.  Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.

Authors:  Lin Lei; Yaping Huang; Wenrong Gong
Journal:  Mol Cell Biochem       Date:  2013-10-27       Impact factor: 3.396

Review 8.  PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective.

Authors:  Palanisamy Nallasamy; Srinivas Chava; Sumit S Verma; Shruti Mishra; Santhi Gorantla; Don W Coulter; Siddappa N Byrareddy; Surinder K Batra; Subash C Gupta; Kishore B Challagundla
Journal:  Semin Cancer Biol       Date:  2017-11-28       Impact factor: 15.707

Review 9.  Reversion inducing cysteine rich protein with Kazal motifs and cardiovascular diseases: The RECKlessness of adverse remodeling.

Authors:  Jacob J Russell; Laurel A Grisanti; Scott M Brown; Chastidy A Bailey; Shawn B Bender; B Chandrasekar
Journal:  Cell Signal       Date:  2021-03-27       Impact factor: 4.850

10.  Deregulation of focal adhesion pathway mediated by miR-659-3p is implicated in bone marrow infiltration of stage M neuroblastoma patients.

Authors:  Sara Stigliani; Paola Scaruffi; Corrado Lagazio; Luca Persico; Barbara Carlini; Luigi Varesio; Fabio Morandi; Martina Morini; Anna Rita Gigliotti; Maria Rosaria Esposito; Elisabetta Viscardi; Valerio Cecinati; Massimo Conte; Maria Valeria Corrias
Journal:  Oncotarget       Date:  2015-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.